Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.01% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
VIR · Jun 30, 2026
Vir Biotechnology, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-26-053549General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
51.61% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
19582.54% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
100.00% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
30.75% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
56.62% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
5.19% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Period transition
What moved in the state?
- Previous
- -1344.83%
- Current
- 0.01%
- Delta
- 1344.84%
- Previous
- -100.96%
- Current
- 19582.54%
- Delta
- 19683.49%
- Previous
- 456172.41%
- Current
- 30.75%
- Delta
- -456141.67%
- Previous
- -41679.31%
- Current
- 5.19%
- Delta
- 41684.50%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Biological Products, (No Diagnostic Substances) peers →Derived From · VIR Company Quality Vector →Has State · Vir Biotechnology, Inc. →Transitioned To · VIR Fundamental State →Transitioned To · VIR CAPEX_INTENSITY_INCREASED →Transitioned To · VIR GROWTH_INCREASED →Transitioned To · VIR PROFITABILITY_DECREASED →Transitioned To · VIR SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.